[Form 4] Envista Holdings Corporation Common stock, $0.01 par value per share Insider Trading Activity
Rhea-AI Filing Summary
Envista Holdings Corp (NVST) insider sale reported. SVP of Strategy & Business Development Mischa Reis sold 15,000 shares of Envista common stock on 08/25/2025 at a price of $21.60 per share, reducing beneficial ownership to 32,382 shares. The filing states the sale was effected pursuant to a previously adopted Rule 10b5-1 trading plan. The Form 4 was signed by Heather Turner by power of attorney on 08/27/2025. The report lists no derivative transactions.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider sold 15,000 NVST shares under a 10b5-1 plan, lowering ownership to 32,382 shares; transaction appears procedural.
The reported sale of 15,000 shares at $21.60 is a straightforward disposition disclosed on Form 4. Because the filing specifies the sale was executed under a Rule 10b5-1 trading plan, timing concerns related to opportunistic insider trading are mitigated by the plan's prearranged nature. The transaction is material only to the extent of the absolute number of shares and the change in beneficial ownership; there are no derivatives or additional transactions disclosed.
TL;DR: Governance controls evident: sale conducted via a 10b5-1 plan and reported on Form 4 with POA signature.
The filing documents appropriate governance procedure: the sale was reported on a timely Form 4 and executed under a 10b5-1 plan, which provides an affirmative defense to insider trading allegations if properly adopted. The Form is signed by a power of attorney, indicating delegated filing responsibility. No conflicts of interest, option exercises, or related-party transactions are disclosed in this submission.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 15,000 | $21.60 | $324K |
Footnotes (1)
- F1. The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
AI-generated analysis. How Rhea-AI works. Not financial advice.